A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Latanoprostene Bunod (Vyzulta)

First FDA approval2017-11-02
Generic availableYes · 1 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$191.0M in CY2024 Part D spend448K claims · 138K beneficiaries · 329 plans surveyed

Lowest NADAC
$102.26/unit
2 NDCs benchmarked, lowest of all strengths.
Average NADAC
$102.36
Across all dosage forms in distribution.
Highest NADAC
$102.46
Range is tight.
Plans with PA
1 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Latanoprostene Bunod used for?

Latanoprostene Bunod is a this drug class medication tracked in Medicare Part D.

Is there a generic for Latanoprostene Bunod?

Yes. 1 ANDAs filed at FDA, 1 generic manufacturers currently shipping.

How much does my plan pay for Latanoprostene Bunod?

Across 329 Part D plans, Latanoprostene Bunod averages $102.36/unit (NADAC). Lowest available: $102.26/unit. Highest in distribution: $102.46/unit.

Is Latanoprostene Bunod on the FDA shortage list?

No. Latanoprostene Bunod is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (2 approvals on file) · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.